Progress in 2012

Filter By:

Article Type
Year
  • In this Progress article, Cossart and colleagues discuss the unique features of unusually long antisense RNAs and discuss the excludon paradigm, which describes a genomic locus that encodes a long antisense RNA which inhibits the expression of one operon while simultaneously driving the expression of the adjacent operon.

    • Nina Sesto
    • Omri Wurtzel
    • Pascale Cossart
    Progress
  • Mucosal-associated invariant T (MAIT) cells have an intrinsic capacity to recognize a broad microbial repertoire through their invariant T cell receptor, which interacts with antigen presented by MHC class I-related protein 1 (MR1). Here, Marielle Gold and David Lewinsohn highlight recent insights suggesting that this unique, 'innate' T cell subset plays an important part in the early recognition and containment of infection.

    • Marielle C. Gold
    • David M. Lewinsohn
    Progress
  • The throughput of protein structure determination has increased greatly over the past decade, thanks to advances in X-ray crystallography and NMR spectroscopy. Protein structure information is now routinely used in vaccine design, and here, Rappuoli and colleagues describe some of the most recent developments in this new field of structural vaccinology.

    • Philip R. Dormitzer
    • Guido Grandi
    • Rino Rappuoli
    Progress
  • A bidirectional neurohumoral communication system known as the gut–brain axis integrates the activities of the intestine and the brain. In this Progress article, Collins, Surette and Bercik describe recent evidence suggesting that the intestinal microbiota is intimately connected with the gut–brain axis and can influence animal behaviour, development and health.

    • Stephen M. Collins
    • Michael Surette
    • Premysl Bercik
    Progress
  • SAMHD1 has emerged as a novel HIV restriction factor that inhibits viral replication by limiting dNTP availability. Here, Schwartz and colleagues discuss the studies that led to the identification and characterization of SAMHD1, and speculate on why HIV-1 does not encode the SAMHD1-targeting protein, Vpx.

    • Diana Ayinde
    • Nicoletta Casartelli
    • Olivier Schwartz
    Progress
  • The search for therapeutics to treat infections by ebolaviruses and Marburg virus has focused on identifying compounds that interfere with viral entry into host cells. Here, White and Schornberg discuss recent studies that have identified Niemann–Pick C1 (NPC1), a protein that resides deep in the endocytic pathway, as an important host factor in this process.

    • Judith M. White
    • Kathryn L. Schornberg
    Progress